(Q36759502)

16 August 2017

1 reference

title

Emerging nanomedicine opportunities with perfluorocarbon nanoparticles (English)

1 reference

16 August 2017

1 reference

0 references

1

Patrick M Winter

1 reference

16 August 2017

Kejia Cai

2

1 reference

16 August 2017

Shelton D Caruthers

series ordinal

3

1 reference

16 August 2017

Samuel A Wickline

series ordinal

4

1 reference

16 August 2017

Gregory M Lanza

series ordinal

5

1 reference

16 August 2017

publication date

1 March 2007

1 reference

Expert Review of Medical Devices

16 August 2017

published in

1 reference

16 August 2017

volume

4

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

137-145

1 reference

Molecular imaging by MRI.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Cellular magnetic resonance imaging: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Magnetic resonance molecular imaging with nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Tumor regression by targeted gene delivery to the neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

In vivo imaging platform for tracking immunotherapeutic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Acoustic characterization in whole blood and plasma of site-targeted nanoparticle ultrasound contrast agent for molecular imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Molecular imaging, targeted therapeutics, and nanoscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Molecular imaging of human thrombus with computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

The potential role of perfluorochemicals (PFCs) in diagnostic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Improved molecular imaging contrast agent for detection of human thrombus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Nanostructured lipid matrices for improved microencapsulation of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Design, Synthesis, and Evaluation of Radiolabeled Integrin αvβ3 Receptor Antagonists for Tumor Imaging and Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Functional anatomy and hemodynamic characteristics of vasa vasorum in the walls of porcine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Plaque angiogenesis: its functions and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Angiogenesis inhibitors: perspectives for medical, surgical and radiation oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Targeted contrast agents for magnetic resonance imaging and ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Tissue factor expression in the morphologic spectrum of vulnerable atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Paclitaxel in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

In stent restenosis: bane of the stent era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Atherosclerotic plaque rupture: local or systemic process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Current status of cellular therapy for ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Intracellular labeling of T-cells with superparamagnetic contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Magnetic resonance microscopy of embryonic cell lineages and movements

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.4.2.137

21 January 2018

Identifiers

DOI

10.1586/17434440.4.2.137

1 reference

16 August 2017

1 reference